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Abstract 
Background: First step in chronic dialysis is establishing a suitable dialysis access. Arteriovenous fistula (AVF) 
has been known as the gold standard for hemodialysis; and due to complex interaction of factors that affect the 
survival time of fistula, we decided to evaluate survival time and affective factors among the dialysis patients. 
Methods: In a historical cohort study, we analyzed 52 patients of the Semnan and Mahdishahr Dialysis 
Centers. The data recorded by history taking and physical examination. 
Results: The survival of fistula was 83%, 80%, 67%, and 40% after 1, 3, 5, and 10 years respectively. Our 
results showed that the survival time of fistula was higher among patients with left-side AVFs. Factors such as 
age, gender, underlying disease, dialysis session per week, the time that patients started dialysis after installing 
fistula and fistula infection did not statistical significant affect the survival time. 
Conclusions: The survival time of AVF among dialysis patients of Semnan and Mahdishahr is satisfying, and 
installing the fistula in left hand lead to higher survival. 
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Introduction 
The first step in chronic dialysis is establishing a 
suitable dialysis access, which can deliver adequate 
blood flow through the dialysis machine that is 300 ml 
it per minute. On the other hand, reaching the long-
term patency of fistula and minimizing the long-term 
and short-term complications of fistula is very 
important (1). Due to complications of primary 
catheters such as infection, stricture or thrombosis; it is 
better to use arteriovenous fistula (AVF) or 
arteriovenous graft for upper extremity as a dialysis 
access (2). 
According to increase in life expectancy and 
number of patients with chronic renal failure (CRF) 
and recognition of AVF as a gold standard of dialysis 
access, performing researches on installing AVF and 
assessment of patency and complications of these 
fistulas has an important role (3). Vascular access 
procedures and complications are major causes for 
hospitalization in dialysis patients; and it has been 
estimated that these factors account for over 20% of 
hospitalization of dialysis patients and cost over one 
billion dollars annually in United States (4). 
Factors that may affect the survival of fistula are 
underlying diseases, surgical procedures and skilled 
staff (5). About 90% of AVFs are patent within 12 
months, but it decrease to 75% after 4 years. In many 
patients fistulas have had good performance for longer, 
even 10 years; which is due to the good condition of 
vessels, patients care and obsessive care of 
hemodialysis technicians (6). According to older 
patients that were referred to dialysis centers in 
Semnan we decided to survey the factors that affect the 
AVF survival to raise survival rate by preventing 
factors that cause failure of fistulas. 
Materials and Methods 
In a historical cohort study, all the patients with end 
stage renal disease whose AVF was used for hemodialysis 
in the Semnan dialysis centers (Fatemiye hospital in 
Semnan and 15th Khordad Hospital in Mahdishahr), 
included total of 52 patients, were analyzed. Data 
analyzed were age, gender, number of fistulization, fistula 
location (right/left and brachial/radial), the time patients 
started dialysis after installing fistula, dialysis sessions per 
week, underlying disease, failed and active fistula survival 
and fistula infection, which recorded by history taking and 
physical examination. Also, we completed our data by 
investigating the patient’s file and by performing an 
interview with patient’s family and dialysis centers 
supervisors. 
The fistula failure definition was: A fistula that 
cannot deliver the optimal dialysis blood-flow, which 
is 300 ml it per minute with two needles. Moreover, the 
diagnostic criteria for fistula infection based on clinical 
findings included: Erythema, cellulitis, tenderness, 
induration, masses, drainage, and sinus tract. 
The data were analyzed by SPSS for windows 
(version 21; IBM Corp., Armonk, NY, USA) by using 
Kaplan–Meyer survival test and cox regression 
analysis. All information about the patients remains 
confidential and secure.  
Results 
In this study, 52 patients were analyzed. The mean age 
of patients was 59.9 ± 14 years, which ranges from 31 
to 83 years. 28 patients (53.8%) were female and 24 
patients (46.2%) were male. 13 patients (25%) had 
failed fistula, which the mean survival time of fistula 
based on the patency time of first fistula was 
36.4 ± 32.3 months. 
In this study, the first survival of fistula was 83% 
and 67% of patients had functioning fistula after 5 
years. (Figure 1) Survey of underlying diseases showed 
that 33 patients (63.5%) were diabetic (Table 1). 
Hypertension was found in 29 patients (55.8%) and 4 
patients (7.7%) had collagen vascular disease. Other 
causes of renal failure such as polycystic kidney 
disease were seen in 10 patients (19.2%). 16 patients 
(30.8%) had right side AVF and 36 patients (69.2%) 
had left side AVF. Forty-three patients (82.7%) had a 
brachial fistula, and 9 patients (17.3%) had a 
radial fistula. 
The mean time of starting dialysis after installing 
the fistula was 68.7 ± 65.3 days that ranges from 10 to 
365 days. The fistula infection rate was 1.9%. 43 cases 
(82.7%) were dialyzed three times, 7 cases (13.5%) 
were dialyzed two times, and 2 patients (3.8%) were 
dialyzed 4 times per week. 
Out of 36 patients with left side fistula only 16.7% 
of patients had fistula failure, while out of 16 patients 
that had right side AVF, 7 patients (43.8%) had fistula 
failure (Table 2). 
Figure 1. Cumulative  survival of arteriovenous fistula in studied patients 
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Table 1. First, second and third year survival of AVF in hemodialysis patients 
Variables First year Second year Third year 
Gender 
Male 0.82 0.82 0.82 
Female 0.85 0.79 0.79 
Diabetes 
Yes 0.84 0.77 0.77 
No 0.84 0.84 0.84 
Blood pressure 
Yes 0.81 0.75 0.75 
No 0.86 0.86 0.86 
Hand 
Left 0.88 0.88 0.88 
Right 0.73 0.62 0.62 
Fistula’s location 
Brachial 0.82 0.78 0.78 
Radial 0.89 0.89 0.89 
Collagen vascular disease 
Yes 0.24 
No 0.87 0.84 0.84 
AVF: Arteriovenous fistula 
Table 2. Variables affect the AVF failure in studied patients 
Variables P-value OR CI95 
Age 0.090 1.02 0.7-2.1 
Gender (female/male) 0.070 1.23 0.8-4.3 
Diabetes 0.090 2.01 0.6-8.2 
Dialysis sessions per week 0.200 0.8 0.4-1.45 
Number of previous arteriovenous fistula 0.070 2.15 0.7-9.1 
Fistula’s site (right hand/left hand) 0.001# 4.7 4.1-16.2 
Collagen vascular disease 0.100 0.6 0.3-1.4 
Dialysis center 0.200 1.01 0.9-2 
#Significant, AVF: Arteriovenous fistula; OR: Odds ratio; CI: Confidence interval 
Discussion 
The mean age of our patients was 59.9 ± 14 years. In 
Erkut et al. study the mean age of patients was 
45 years (7). 
In this study, age and gender did not have a 
significant relationship with survival time. This data is 
identical to the results of studies that showed age and 
gender does not affect the survival time of AVF 
(6,8-11). 
In this study, the survival time was 83%, 75% and 
67% after 1, 4 and 5 years respectively. In Salahi study, 
first year survival was 94% and in Xue study was 90%, 
which is almost identical to our results (12,13). 
In Croatia study, the 1st year and the 5th year 
survival was 73% and 36% respectively, which the 
survival time in our study was higher (9). 
In Yazd study, the 1st and 4th year survival was 
90.9% and 43.6% respectively, which the 4th year 
survival was higher in our study (6). 
These data shows that the 1st year survival of AVF 
in Semnan is almost as same as the centers above; but 
long term survival of our fistulas are higher compared 
to the centers above. 
In this study, three underlying diseases were studied 
that 33 patients had diabetes, 29 patients had HTN and 
4 patients had CVD. In this study, underlying disease 
did not affect the survival time. 
This data confirm the Salahi study that showed 
diabetes and HTN did not affect the survival, consistent 
with Yazd study (6,12); and opposite to Smith and 
Erkut et al. that indicated, diabetes reduced AVF 
survival (7,10). 
Opposite to the results of Puskar study that diabetes 
was in fourth place of causes of CRF (9). In our study, 
diabetes and hypertension were two major causes of 
CRF in dialysis patients. 
In this study, patients with left side AVFs were 
more than patients with right side AVFs. In addition 
our result showed fistula survival was higher among 
the patients with left side AVF. In the same study, 
survival was lower in right hand (12). 
Our results confirm that location of fistula 
(brachial/radial) didn’t affect the survival, which is 
similar to Erkut et al. study (7). Puskar showed that 
proximal forearm fistula survived longer than the distal 
one in opposite to Ates opinion, that recommend distal 
part of forearm for fistulization because of prolonged 
survival in this part (9,14). 
In this study, mean time for starting dialysis after 
fistulization was 68.7 ± 65.3 days that this finding had 
not significant impact on survival. Moreover, Rayner 
16    Acad J Surg, Vol. 2, No. 1-2 (2015)
Factors Affecting AVF Survival 
showed that starting dialysis after 14 days do not affect 
the survival time, which this finding is almost similar 
to our study (15). 
Saran showed that earlier cannulation of a newly 
placed vascular access was not associated with 
increased risk of vascular access failure and kybartiene 
indicated that AVFs of the patients who started planned 
hemodialysis functioned longer as compared to AVFs 
of the patients who started hemodialysis urgently 
(8,16). 
In this study, dialysis sessions per week had not a 
statistically significant impact on survival, opposite to 
some studies showed AVF survival was directly 
dependent on either the number of hours or the number 
of hemodialysis sessions per week (7,9). The limitation 
of this study is the few number of patients in Semnan, 
which makes the compression difficult. 
Conclusion 
The follow-up study of AVFs has been shown that 
although the average age of the patients of this study is 
higher than similar studies; and the patients has had 
high-risk factors such as diabetes and high blood 
pressure, the survival rate of fistula is acceptable. 
Insertion of the fistula on the left arm has had a 
reduction on repeated surgeries as well as much longer 
functioning performance. 
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